Use of cell lines in the investigation of pharmacogenetic loci

Current Pharmaceutical Design

Volumn 15, Issue 32, 2009, Pages 3782-3795

  Zhang, Wei ^a   Dolan, M Eileen ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Drug response; Gene expression; HapMap; Lymphoblastoid cell lines; Pharmacogenomics; Single nucleotide polymorphism; Toxicity

Indexed keywords

APOPTOSIS; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE LOCUS; GENETIC PREDISPOSITION; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE MAP; HUMAN; HUMAN GENOME; IMMOBILIZED CELL CULTURE; LYMPHOBLASTOID CELL LINE; PHARMACOGENETICS; PHARMACOGENOMICS; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; TOXICOGENETICS;

ANTINEOPLASTIC AGENTS; CELL LINE; DRUG TOXICITY; GENE EXPRESSION; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NEOPLASMS; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI;

EID: 70449669316     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209789649475     Document Type: Review

References (145)

1. Ingelman-Sundberg M. Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms. Naunyn Schmiedebergs Arch Pharmacol 2004; 369: 89-104. (Pubitemid 38161226)
2. Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf 2007; 2: 79-87. (Pubitemid 46723172)
3. The International HapMap Consortium. The International HapMap Project. Nature 2003; 426: 789-796
4. The International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437: 1299-1320
5. Biason P, Masier S, Toffoli G. UGT1A1*28 and other UGT1A polymorphisms as determinants of irinotecan toxicity. J Chemother 2008; 20: 158-165 (Pubitemid 351797053)
6. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921. (Pubitemid 32165345)
7. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science 2001; 291: 1304-1351
8. Ratain MJ. Personalized medicine: building the GPS to take us there. Clin Pharmacol Ther 2007; 81: 321-322 (Pubitemid 46364492)
9. Ratain MJ. Finding the right dose. Clin Adv Hematol Oncol 2003; 1: 517-8, 31.
10. Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 2008; 82: 937-948
11. Dunning AM, Healey CS, Baynes C, Scollen S, Vega A, Rodriguez R, et al. Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 2009; 18(6): 1131-1139
12. Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, Helgadottir A, et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009; 41: 18-24.
13. Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, Furuta H, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008; 40(9): 1092-1097
14. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008; 40: 768-775 (Pubitemid 351748863)
15. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008; 40: 161-169 (Pubitemid 351171403)
16. Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, et al. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet 2008; 83: 623-632
17. Weedon MN, Lango H, Lindgren CM, Wallace C, Evans DM, Mangino M, et al. Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet 2008; 40: 575-583 (Pubitemid 351601210)
18. Sulem P, Gudbjartsson DF, Stacey SN, Helgason A, Rafnar T, Magnusson KP, et al. Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat Genet 2007; 39: 1443-1452 (Pubitemid 350191337)
19. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409: 928-933 (Pubitemid 32165347)
20. Jorde LB, Wooding SP. Genetic variation, classification and 'race'. Nat Genet 2004; 36: S28-33.
21. Jorde LB, Watkins WS, Bamshad MJ, Dixon ME, Ricker CE, Seielstad MT, et al. The distribution of human genetic diversity: a comparison of mitochondrial, autosomal, and Y-chromosome data. Am J Hum Genet 2000; 66: 979-988
22. Barbujani G, Magagni A, Minch E, Cavalli-Sforza LL. An apportionment of human DNA diversity. Proc Natl Acad Sci USA 1997; 94: 4516-4519
23. Wong KK, deLeeuw RJ, Dosanjh NS, Kimm LR, Cheng Z, Horsman DE, et al. A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet 2007; 80: 91-104.
24. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, et al. Global variation in copy number in the human genome. Nature 2006; 444: 444-454 (Pubitemid 44809057)
25. Freeman JL, Perry GH, Feuk L, Redon R, McCarroll SA, Altshuler DM, et al. Copy number variation: new insights in genome diversity. Genome Res 2006; 16: 949-961 (Pubitemid 44162254)
26. McCarroll SA, Altshuler DM. Copy-number variation and association studies of human disease. Nat Genet 2007; 39: S37-42.
27. Dolan ME, Newbold KG, Nagasubramanian R, Wu X, Ratain MJ, Cook EH, Jr., et al. Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity. Cancer Res 2004; 64: 4353-4356 (Pubitemid 38802443)
28. Anderson GD. Gender differences in pharmacological response. Int Rev Neurobiol 2008; 83: 1-10.
29. Maitland ML, DiRienzo A, Ratain MJ. Interpreting disparate responses to cancer therapy: the role of human population genetics. J Clin Oncol 2006; 24: 2151-2157 (Pubitemid 46630687)
30. Rodman JH, Relling MV, Stewart CF, Synold TW, McLeod H, Kearns C, et al. Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in children. Semin Oncol 1993; 20: 18-29. (Pubitemid 23082215)
31. Olas B, Wachowicz B. Cisplatin-induced changes in biological activity of blood platelets: thiol-related mechanisms. Anticancer Drugs 1996; 7: 476-482 (Pubitemid 26249201)
32. Icli F, Karaoguz H, Dincol D, Demirkazik A, Gunel N, Karaoguz R, et al. Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer 1993; 72: 587-593 (Pubitemid 23193472)
33. Verstappen CC, Heimans JJ, Hoekman K, Postma TJ. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 2003; 63: 1549-1563 (Pubitemid 36976138)
34. Daugaard G. Cisplatin nephrotoxicity: experimental and clinical studies. Dan Med Bull 1990; 37: 1-12. (Pubitemid 20123139)
35. Chatelut E, Delord JP, Canal P. Toxicity patterns of cytotoxic drugs. Invest New Drugs 2003; 21: 141-148
36. Zhang W, Ratain MJ, Dolan ME. The HapMap resource is providing new insights into ourselves and its application to pharmacogenomics. Bioinform Biol Insights 2008; 2: 15-23.
37. Voight BF, Kudaravalli S, Wen X, Pritchard JK. A map of recent positive selection in the human genome. PLoS Biol 2006; 4: e72.
38. Dausset J, Cann H, Cohen D, Lathrop M, Lalouel JM, White R. Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics 1990; 6: 575-577 (Pubitemid 20168693)
39. Thorisson GA, Stein LD. The SNP Consortium website: past, present and future. Nucleic Acids Res 2003; 31: 124-127 (Pubitemid 36150350)
40. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, Spielman RS, et al. Genetic analysis of genome-wide variation in human gene expression. Nature 2004; 430: 743-747 (Pubitemid 39071339)
41. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007; 449: 851-861
42. Thorisson GA, Smith AV, Krishnan L, Stein LD. The International HapMap Project Web site. Genome Res 2005; 15: 1592-1593 (Pubitemid 41545013)
43. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, et al. Detection of large-scale variation in the human genome. Nat Genet 2004; 36: 949-951 (Pubitemid 39167488)
44. Zhang J, Feuk L, Duggan GE, Khaja R, Scherer SW. Development of bioinformatics resources for display and analysis of copy number and other structural variants in the human genome. Cytogenet Genome Res 2006; 115: 205-214 (Pubitemid 44832022)
45. Payseur BA, Place M, Weber JL. Linkage disequilibrium between STRPs and SNPs across the human genome. Am J Hum Genet 2008; 82: 1039-1050
46. Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, Cheung VG. Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet 2007; 39: 226-231 (Pubitemid 46184354)
47. Price AL, Patterson N, Hancks DC, Myers S, Reich D, Cheung VG, et al. Effects of cis and trans genetic ancestry on gene expression in African Americans. PLoS Genet 2008; 4: e1000294.
48. Storey JD, Madeoy J, Strout JL, Wurfel M, Ronald J, Akey JM. Gene-expression variation within and among human populations. Am J Hum Genet 2007; 80: 502-509 (Pubitemid 46310982)
49. Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, Beazley C, et al. Population genomics of human gene expression. Nat Genet 2007; 39: 1217-1224 (Pubitemid 47482691)
50. Zhang W, Duan S, Bleibel WK, Wisel SA, Huang RS, Wu X, et al. Identification of common genetic variants that account for transcript isoform variation between human populations. Hum Genet 2008; 125: 81-93.
51. Zhang W, Duan S, Kistner EO, Bleibel WK, Huang RS, Clark TA, et al. Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Hum Genet 2008; 82: 631-640
52. Kapur K, Xing Y, Ouyang Z, Wong WH. Exon arrays provide accurate assessments of gene expression. Genome Biol 2007; 8: R82. (Pubitemid 351895145)
53. Klein TE, Chang JT, Cho MK, Easton KL, Fergerson R, Hewett M, et al. Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Pharmacogenomics J 2001; 1: 167-170
54. Cheung VG, Conlin LK, Weber TM, Arcaro M, Jen KY, Morley M, et al. Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet 2003; 33: 422-425
55. Cheung VG, Spielman RS. The genetics of variation in gene expression. Nat Genet 2002; 32 Suppl: 522-525 (Pubitemid 35435156)
56. Stranger BE, Forrest MS, Clark AG, Minichiello MJ, Deutsch S, Lyle R, et al. Genome-wide associations of gene expression variation in humans. PLoS Genet 2005; 1: e78.
57. Cheung VG, Spielman RS, Ewens KG, Weber TM, Morley M, Burdick JT. Mapping determinants of human gene expression by regional and genome-wide association. Nature 2005; 437: 1365-1369 (Pubitemid 41568683)
58. Zhang W, Bleibel WK, Roe CA, Cox NJ, Eileen Dolan M. Gender-specific differences in expression in human lymphoblastoid cell lines. Pharmacogenet Genomics 2007; 17: 447-450 (Pubitemid 46763389)
59. Zhang W, Huang RS, Duan S, Dolan ME. Gene set enrichment analyses revealed differences in gene expression patterns between males and females. In Silico Biol 2009; 9: 0006.
60. Duan S, Huang RS, Zhang W, Bleibel WK, Roe CA, Clark TA, et al. Genetic architecture of transcript-level variation in humans. Am J Hum Genet 2008; 82: 1101-1113
61. Gilad Y, Rifkin SA, Pritchard JK. Revealing the architecture of gene regulation: the promise of eQTL studies. Trends Genet 2008; 24: 408-415
62. Kwan T, Benovoy D, Dias C, Gurd S, Serre D, Zuzan H, et al. Heritability of alternative splicing in the human genome. Genome Res 2007; 17: 1210-1218 (Pubitemid 47204865)
63. Kwan T, Benovoy D, Dias C, Gurd S, Provencher C, Beaulieu P, et al. Genome-wide analysis of transcript isoform variation in humans. Nat Genet 2008; 40: 225-231 (Pubitemid 351171391)
64. Huang RS, Kistner EO, Bleibel WK, Shukla SJ, Dolan ME. Effect of population and gender on chemotherapeutic agent-induced cytotoxicity. Mol Cancer Ther 2007; 6: 31-36
65. Huang RS, Duan S, Kistner EO, Zhang W, Bleibel WK, Cox NJ, et al. Identification of genetic variants and gene expression relationships associated with pharmacogenes in humans. Pharmacogenet Genomics 2008; 18: 545-549 (Pubitemid 351769922)
66. Gipps EM, Kidson C. Cellular radiosensitivity: expression of an MS susceptibility gene? Neurology 1984; 34: 808-811
67. Imray FP, Smith PJ, Relf W, Kidson C. Wilms' tumour: association with cellular sensitivity to mitomycin C in patients and first-degree relatives. Lancet 1984; 1: 1148-1151 (Pubitemid 14108708)
68. Poot M, Gollahon KA, Rabinovitch PS. Werner syndrome lymphoblastoid cells are sensitive to camptothecin-induced apoptosis in S-phase. Hum Genet 1999; 104: 10-14 (Pubitemid 29134635)
69. Cloos J, Nieuwenhuis EJ, Boomsma DI, Kuik DJ, van der Sterre ML, Arwert F, et al. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes. J Natl Cancer Inst 1999; 91: 1125-1130 (Pubitemid 29330550)
70. Jen KY, Cheung VG. Transcriptional response of lymphoblastoid cells to ionizing radiation. Genome Res 2003; 13: 2092-2100 (Pubitemid 37161766)
71. Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 2001; 27: 383-391 (Pubitemid 32268418)
72. Giacomini KM, Brett CM, Altman RB, Benowitz NL, Dolan ME, Flockhart DA, et al. The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther 2007; 81: 328-345
73. Zhou S. Clinical pharmacogenomics of thiopurine S-methyltransferase. Curr Clin Pharmacol 2006; 1: 119-128
74. Johnatty SE, Beesley J, Paul J, Fereday S, Spurdle AB, Webb PM, et al. ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy. Clin Cancer Res 2008; 14: 5594-5601
75. Jones TS, Yang W, Evans WE, Relling MV. Using HapMap tools in pharmacogenomic discovery: the thiopurine methyltransferase polymorphism. Clin Pharmacol Ther 2007; 81: 729-734 (Pubitemid 46625112)
76. Lamba JK, Crews K, Pounds S, Schuetz EG, Gresham J, Gandhi V, et al. Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants. J Pharmacol Exp Ther 2007; 323: 935-945 (Pubitemid 350146062)
77. Watters JW, Kraja A, Meucci MA, Province MA, McLeod HL. Genome-wide discovery of loci influencing chemotherapy cytotoxicity. Proc Natl Acad Sci U S A 2004; 101: 11809-11814 (Pubitemid 39095376)
78. Duan S, Bleibel WK, Huang RS, Shukla SJ, Wu X, Badner JA, et al. Mapping genes that contribute to daunorubicin-induced cytotoxicity. Cancer Res 2007; 67: 5425-5433 (Pubitemid 46997283)
79. Bleibel WK, Duan S, Huang RS, Kistner EO, Shukla SJ, Wu X, et al. Identification of genomic regions contributing to etoposide-induced cytotoxicity. Hum Genet 2008; [Epub ahead of print].
80. Huang RS, Duan S, Bleibel WK, Kistner EO, Zhang W, Clark TA, et al. A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc Natl Acad Sci USA 2007; 104: 9758-9763 (Pubitemid 47175340)
81. Huang RS, Duan S, Kistner EO, Bleibel WK, Delaney SM, Fackenthal DL, et al. Genetic variants contributing to daunorubicin-induced cytotoxicity. Cancer Res 2008; 68: 3161-3168
82. Huang RS, Duan S, Kistner EO, Hartford CM, Dolan ME. Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans. Mol Cancer Ther 2008; 7: 3038-3046
83. Huang RS, Duan S, Shukla SJ, Kistner EO, Clark TA, Chen TX, et al. Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Am J Hum Genet 2007; 81: 427-437 (Pubitemid 47330203)
84. Hartford CM, Duan S, Delaney SM, Mi S, Kistner EO, Lamba JK, et al. Population specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity. Blood 2008; [Epub ahead of print].
85. French D, Yang W, Cheng C, Raimondi SC, Mullighan CG, Downing JR, et al. Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemia. Blood 2008;
86. Pottier N, Cheok MH, Yang W, Assem M, Tracey L, Obenauer JC, et al. Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression. Hum Mol Genet 2007; 16: 2261-2271 (Pubitemid 47423892)
87. Hartford C, Yang W, Cheng C, Fan Y, Liu W, Trevino L, et al. Genome scan implicates adhesion biological pathways in secondary leukemia. Leukemia 2007; 21: 2128-2136 (Pubitemid 47423802)
88. Yang J, Bogni A, Cheng C, Bleibel WK, Cai X, Fan Y, et al. Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia. Clin Pharmacol Ther 2008; 84: 691-697
89. French D, Yang W, Hamilton LH, Neale G, Fan Y, Downing JR, et al. Concordant gene expression in leukemia cells and normal leukocytes is associated with germline cis-SNPs. PLoS ONE 2008; 3: e2144. (Pubitemid 352025164)
90. Lamba JK, Chen X, Lan LB, Kim JW, Wei Wang X, Relling MV, et al. Increased CYP3A4 copy number in TONG/HCC cells but not in DNA from other humans. Pharmacogenet Genomics 2006; 16: 415-427 (Pubitemid 43804799)
91. Choy E, Yelensky R, Bonakdar S, Plenge RM, Saxena R, De Jager PL, et al. Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines. PLoS Genet 2008; 4: e1000287.
92. Dezso Z, Nikolsky Y, Sviridov E, Shi W, Serebriyskaya T, Dosymbekov D, et al. A comprehensive functional analysis of tissue specificity of human gene expression. BMC Biol 2008; 6: 49.
93. Crawford DC, Akey DT, Nickerson DA. The patterns of natural variation in human genes. Annu Rev Genomics Hum Genet 2005; 6: 287-312. (Pubitemid 41397085)
94. Abdueva D, Wing MR, Schaub B, Triche TJ. Experimental comparison and evaluation of the Affymetrix exon and U133Plus2 GeneChip arrays. PLoS ONE 2007; 2: e913.
95. Robinson MD, Speed TP. A comparison of Affymetrix gene expression arrays. BMC Bioinformatics 2007; 8: 449.
96. Gilad Y, Rifkin SA, Bertone P, Gerstein M, White KP. Multispecies microarrays reveal the effect of sequence divergence on gene expression profiles. Genome Res 2005; 15: 674-680 (Pubitemid 41043637)
97. Alberts R, Terpstra P, Li Y, Breitling R, Nap JP, Jansen RC. Sequence polymorphisms cause many false cis eQTLs. PLoS ONE 2007; 2: e622. (Pubitemid 351279929)
98. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001; 29: 308-311 (Pubitemid 32054478)
99. Duan S, Zhang W, Bleibel WK, Cox NJ, Dolan ME. SNPinProbe-1.0: A database for filtering out probes in the Affymetrix GeneChip(R) Human Exon 1.0 ST array potentially affected by SNPs. Bioinformation 2008; 2: 469-470
100. Benovoy D, Kwan T, Majewski J. Effect of polymorphisms within probe-target sequences on olignonucleotide microarray experiments. Nucleic Acids Res 2008; 36: 4417-4423
101. Pradervand S, Paillusson A, Thomas J, Weber J, Wirapati P, Hagenbuchle O, et al. Affymetrix Whole-Transcript Human Gene 1.0 ST array is highly concordant with standard 3' expression arrays. Biotechniques 2008; 44: 759-762 (Pubitemid 351839144)
102. Okoniewski MJ, Hey Y, Pepper SD, Miller CJ. High correspondence between Affymetrix exon and standard expression arrays. Biotechniques 2007; 42: 181-185
103. Akey JM, Biswas S, Leek JT, Storey JD. On the design and analysis of gene expression studies in human populations. Nat Genet 2007; 39: 807-8; author reply 8-9. (Pubitemid 47014480)
104. Speck P, Haan KM, Longnecker R. Epstein-Barr virus entry into cells. Virology 2000; 277: 1-5.
105. Yates JL, Warren N, Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 1985; 313: 812-815 (Pubitemid 15130835)
106. Morris MA, Dawson CW, Wei W, O'Neil JD, Stewart SE, Jia J, et al. Epstein-Barr virus-encoded LMP1 induces a hyperproliferative and inflammatory gene expression programme in cultured keratinocytes. J Gen Virol 2008; 89: 2806-2820
107. Zimber-Strobl U, Strobl LJ. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Semin Cancer Biol 2001; 11: 423-434 (Pubitemid 33105021)
108. Kaaijk P, Kaspers GJ, Van Wering ER, Broekema GJ, Loonen AH, Hahlen K, et al. Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia. Br J Cancer 2003; 88: 775-781
109. Mardis ER. Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet 2008; 9: 387-402.
110. Mardis ER. The impact of next-generation sequencing technology on genetics. Trends Genet 2008; 24: 133-141
111. The ENCODE Consortium. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 2004; 306: 636-640
112. Livingston RJ, von Niederhausern A, Jegga AG, Crawford DC, Carlson CS, Rieder MJ, et al. Pattern of sequence variation across 213 environmental response genes. Genome Res 2004; 14: 1821-1831 (Pubitemid 39386496)
113. Smigielski EM, Sirotkin K, Ward M, Sherry ST. dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res 2000; 28: 352-355 (Pubitemid 30047805)
114. Kuehn BM. 1000 Genomes Project promises closer look at variation in human genome. JAMA 2008; 300: 2715.
115. The 1000 Genomes Project]. Meeting Report: A workshop to plan a deep catalog of human genetic variation. 2007; [http://www. 1000genomes.org].
116. Zhang W, Dolan ME. Beyond the HapMap genotypic data: prospects of deep resequencing projects. Curr Bioinformatics 2008; 3: 178-182
117. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007; 315: 848-853 (Pubitemid 46255837)
118. Greshock J, Cheng J, Rusnak D, Martin AM, Wooster R, Gilmer T, et al. Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines. Mol Cancer Ther 2008; 7: 935-943 (Pubitemid 351551047)
119. Cappuzzo F, Varella-Garcia M, Shigematsu H, Domenichini I, Bartolini S, Ceresoli GL, et al. Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients. J Clin Oncol 2005; 23: 5007-5018 (Pubitemid 46224007)
120. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006; 38: 1378-1385
121. Brown R, Glasspool R. Epigenetic modulation of resistance to chemotherapy? Ann Oncol 2007; 18: 1429-1430
122. Strathdee G. Epigenetic markers and response to chemotherapy in cancer. Dis Markers 2007; 23: 43-49 (Pubitemid 46333642)
123. Gius D, Bradbury CM, Sun L, Awwad RT, Huang L, Smart DD, et al. The epigenome as a molecular marker and target. Cancer 2005; 104: 1789-1793
124. Kaina B, Fritz G, Ochs K, Haas S, Grombacher T, Dosch J, et al. Transgenic systems in studies on genotoxicity of alkylating agents: critical lesions, thresholds and defense mechanisms. Mutat Res 1998; 405: 179-191 (Pubitemid 29042194)
125. Gerson SL. MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer 2004; 4: 296-307. (Pubitemid 38525285)
126. Rabik CA, Njoku MC, Dolan ME. Inactivation of O6-alkylguanine DNA alkyltransferase as a means to enhance chemotherapy. Cancer Treat Rev 2006; 32: 261-276
127. Esteller M, Gaidano G, Goodman SN, Zagonel V, Capello D, Botto B, et al. Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J Natl Cancer Inst 2002; 94: 26-32.
128. Zuo C, Ai L, Ratliff P, Suen JY, Hanna E, Brent TP, et al. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2004; 13: 967-975 (Pubitemid 38756707)
129. Novoyatleva T, Tang Y, Rafalska I, Stamm S. Pre-mRNA missplicing as a cause of human disease. Prog Mol Subcell Biol 2006; 44: 27-46.
130. Faustino NA, Cooper TA. Pre-mRNA splicing and human disease. Genes Dev 2003; 17: 419-437
131. Brinkman BM. Splice variants as cancer biomarkers. Clin Biochem 2004; 37: 584-594
132. Alves R, Vilaprinyo E, Sorribas A. Integrating bioinformatics and computational biology: perspectives and possibilities for In Silico network reconstruction in molecular systems biology. Curr Bioinformatics 2008; 3: 98-129.
133. Zhang W, Huang RS, Dolan ME. Integrating epigenomics into pharmacogenomic studies. Pharmacogenomics Personalized Med 2008; 1: 7-14.
134. Zhang W, Liu W, Innocenti F, Ratain MJ. Searching for tissue-specific expression pattern-linked nucleotides of UGT1A isoforms. PLoS ONE 2007; 2: e396.
135. Schadt EE, Molony C, Chudin E, Hao K, Yang X, Lum PY, et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol 2008; 6: e107. (Pubitemid 351824739)
136. Shoemaker RH. The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 2006; 6: 813-823
137. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, et al. A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000; 24: 236-244 (Pubitemid 30132190)
138. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000; 24: 227-235 (Pubitemid 30132189)
139. Blower PE, Verducci JS, Lin S, Zhou J, Chung JH, Dai Z, et al. MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther 2007; 6: 1483-1491 (Pubitemid 46954015)
140. Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005; 436: 117-122 (Pubitemid 40966196)
141. Zhang W, Liu W, Poradosu E, Ratain M. Genome-wide identification of genetic determinants for the cytotoxicity of perifosine. Hum Genomics 2008; 3: 53-70.
142. Liu W, Wu X, Zhang W, Montenegro RC, Fackenthal DL, Spitz JA, et al. Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines. Clin Cancer Res 2007; 13: 6788-6795 (Pubitemid 350206817)
143. Altmann KH, Memmert K. Epothilones as lead structures for new anticancer drugs-pharmacology, fermentation, and structure-activity-relationships. Prog Drug Res 2008; 66: 273, 275-334.
144. Detzer A, Overhoff M, Mescalchin A, Rompf M, Sczakiel G. Phosphorothioate-stimulated cellular uptake of siRNA: a cell culture model for mechanistic studies. Curr Pharm Des 2008; 14(34): 3666-3673
145. Gueant JL, Gueant-Rodriguez RM, Gastin IA, Cornejo-Garcia JA, Viola M, Barbaud A, et al. Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivity. Curr Pharm Des 2008; 14(27): 2770-2777